COLLEGIUM PHARMACEUTICAL, INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2015 to Q2 2024.
  • Collegium Pharmaceutical, Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $10M, a 41.6% increase year-over-year.
  • Collegium Pharmaceutical, Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $31.5M, a 30.5% increase year-over-year.
  • Collegium Pharmaceutical, Inc annual Share-based Payment Arrangement, Expense for 2023 was $27.1M, a 18.6% increase from 2022.
  • Collegium Pharmaceutical, Inc annual Share-based Payment Arrangement, Expense for 2022 was $22.9M, a 5.69% decline from 2021.
  • Collegium Pharmaceutical, Inc annual Share-based Payment Arrangement, Expense for 2021 was $24.3M, a 10.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $31.5M $10M +$2.94M +41.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $28.6M $7.48M +$1.44M +23.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $27.1M $7M +$1.33M +23.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $25.8M $7.03M +$1.65M +30.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $24.2M $7.07M +$1.38M +24.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $22.8M $6.04M -$100K -1.63% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $22.9M $5.67M +$758K +15.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $22.1M $5.38M -$571K -9.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $22.7M $5.69M -$824K -12.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $23.5M $6.14M -$744K -10.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $24.3M $4.91M -$1.3M -20.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $25.6M $5.95M +$783K +15.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $24.8M $6.52M +$932K +16.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $23.8M $6.88M +$1.93M +38.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $21.9M $6.21M +$2.24M +56.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $19.7M $5.17M +$1.03M +24.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $18.6M $5.58M +$1.42M +34.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $17.2M $4.95M +$688K +16.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $16.5M $3.97M +$368K +10.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $16.2M $4.14M +$211K +5.37% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $15.9M $4.16M +$636K +18% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $15.3M $4.26M +$1.54M +56.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $13.8M $3.6M +$1.52M +73.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $12.3M $3.93M +$1.83M +87% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $10.4M $3.53M +$1.58M +81.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $8.85M $2.73M +$907K +49.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $7.95M $2.08M +$428K +25.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $7.52M $2.1M +$459K +28% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $7.06M $1.95M +$551K +39.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $6.51M $1.82M +$720K +65.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $5.79M $1.65M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $1.64M +$1.14M +226% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $1.4M +$794K +132% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.1M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 $503K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $601K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.